| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |